Vitamin D status among preterm and full-term infants at birth

Heather H Burris1, Linda J Van Marter2, Thomas F McElrath3

  • 11] Harvard Medical School, Boston, Massachusetts [2] Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts [3] Division of Newborn Medicine, Boston Children's Hospital, Boston, Massachusetts.

Pediatric Research
|October 15, 2013
PubMed

Insights

Very preterm infants (<32 weeks gestation) have higher odds of low vitamin D levels at birth. This finding highlights the need for further research into vitamin D

Area of Science:

  • Neonatal Medicine
  • Maternal-Fetal Health
  • Nutritional Biochemistry

Background:

  • Maternal vitamin D deficiency and preterm birth share risk factors.
  • The specific vitamin D status of preterm infants is not well-characterized.
  • Understanding 25-hydroxyvitamin D (25(OH)D) levels in neonates is crucial.

Purpose of the Study:

  • To investigate the association between cord plasma 25-hydroxyvitamin D (25(OH)D) levels and gestational age.
  • To determine if preterm infants have lower 25(OH)D levels compared to term infants.

Main Methods:

  • Umbilical cord plasma 25(OH)D levels were measured in 471 infants.
  • Generalized estimating equations were used to analyze the odds of low 25(OH)D (<20 ng/ml).
  • Analyses adjusted for season of birth, maternal age, race, marital status, and gestation type.

Main Results:

  • The mean cord plasma 25(OH)D level was 34.0 ng/ml.
  • Infants born before 32 weeks gestation had significantly increased odds of low 25(OH)D levels.
  • Adjusted models showed an odds ratio of 2.4 (95% CI: 1.2-5.3) for very preterm infants having low vitamin D.

Conclusions:

  • Infants born before 32 weeks gestation are at a higher risk for low vitamin D levels at birth.
  • These findings suggest a potential link between low 25(OH)D and preterm birth.
  • Further research is warranted to explore the implications of low vitamin D in preterm infants and its sequelae.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
8.2K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
73
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
75
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982